- Home
- PXLW vs DXR Comparison
PXLW vs DXR Comparison
Compare PXLW & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXLW
- DXR
- Stock Information
- Founded
- PXLW 1997
- DXR 1970
- Country
- PXLW United States
- DXR United States
- Employees
- PXLW N/A
- DXR N/A
- Industry
- PXLW Semiconductors
- DXR Medical/Dental Instruments
- Sector
- PXLW Technology
- DXR Health Care
- Exchange
- PXLW Nasdaq
- DXR Nasdaq
- Market Cap
- PXLW 50.2M
- DXR 46.9M
- IPO Year
- PXLW 2000
- DXR N/A
- Fundamental
- Price
- PXLW $9.72
- DXR $11.20
- Analyst Decision
- PXLW Strong Buy
- DXR Strong Buy
- Analyst Count
- PXLW 3
- DXR 1
- Target Price
- PXLW $13.67
- DXR $25.00
- AVG Volume (30 Days)
- PXLW 120.1K
- DXR 10.4K
- Earning Date
- PXLW 08-12-2025
- DXR 01-01-0001
- Dividend Yield
- PXLW N/A
- DXR N/A
- EPS Growth
- PXLW N/A
- DXR 3.46
- EPS
- PXLW N/A
- DXR 0.36
- Revenue
- PXLW $33,961,000.00
- DXR $66,306.00
- Revenue This Year
- PXLW N/A
- DXR N/A
- Revenue Next Year
- PXLW $25.33
- DXR N/A
- P/E Ratio
- PXLW N/A
- DXR $30.67
- Revenue Growth
- PXLW N/A
- DXR N/A
- 52 Week Low
- PXLW $4.67
- DXR $6.55
- 52 Week High
- PXLW $15.03
- DXR $11.48
- Technical
- Relative Strength Index (RSI)
- PXLW 55.03
- DXR 57.09
- Support Level
- PXLW $7.97
- DXR $10.27
- Resistance Level
- PXLW $8.62
- DXR $11.48
- Average True Range (ATR)
- PXLW 0.97
- DXR 0.54
- MACD
- PXLW 0.06
- DXR -0.02
- Stochastic Oscillator
- PXLW 62.25
- DXR 81.08
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.